Rezolute, Inc.

( )
RZLT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Technology Services » Internet Software Or Services
FBFacebook, Inc. -1.15%324.760.7%$7050.03m
GOOGLAlphabet, Inc. 0.15%2827.360.5%$4318.66m
GOOGAlphabet, Inc. 0.19%2833.500.5%$3512.96m
AFRMAffirm Holdings, Inc. -1.17%146.730.0%$2858.79m
UPSTUpstart Holdings, Inc. 2.72%390.000.0%$1987.41m
SNAPSnap, Inc. 0.74%77.212.3%$1282.85m
SESea Ltd. (Singapore) 2.65%354.513.1%$1018.72m
MTCHMatch Group, Inc. 1.92%160.024.3%$846.29m
TWTRTwitter, Inc. -0.65%62.768.8%$667.79m
DKNGDraftKings, Inc. -2.59%48.080.0%$626.50m
DASHDoorDash, Inc. 0.77%214.060.0%$569.47m
MELIMercadoLibre, Inc. 2.55%1563.093.6%$561.28m
BIDUBaidu, Inc. 0.57%163.632.3%$533.64m
MSTRMicroStrategy, Inc. 3.58%749.853.0%$403.73m
PINSPinterest, Inc. 0.29%52.670.0%$362.21m

Company Profile

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.